nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2C8—Mometasone—systemic scleroderma	0.192	0.267	CbGbCtD
Isoniazid—CYP1A2—Pentoxifylline—systemic scleroderma	0.1	0.139	CbGbCtD
Isoniazid—CYP1A2—Leflunomide—systemic scleroderma	0.0958	0.133	CbGbCtD
Isoniazid—CYP2C9—Leflunomide—systemic scleroderma	0.0863	0.12	CbGbCtD
Isoniazid—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0764	0.106	CbGbCtD
Isoniazid—CYP2D6—Captopril—systemic scleroderma	0.0619	0.086	CbGbCtD
Isoniazid—CYP2C19—Prednisone—systemic scleroderma	0.0513	0.0712	CbGbCtD
Isoniazid—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.031	0.0431	CbGbCtD
Isoniazid—CYP3A4—Prednisone—systemic scleroderma	0.0248	0.0344	CbGbCtD
Isoniazid—Emotional distress—Pentoxifylline—systemic scleroderma	0.00841	0.03	CcSEcCtD
Isoniazid—Diabetic—Captopril—systemic scleroderma	0.00812	0.029	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Azathioprine—systemic scleroderma	0.00708	0.0253	CcSEcCtD
Isoniazid—Atrophy—Mycophenolic acid—systemic scleroderma	0.00654	0.0233	CcSEcCtD
Isoniazid—Diabetic—Lisinopril—systemic scleroderma	0.00575	0.0205	CcSEcCtD
Isoniazid—Atrophy—Mycophenolate mofetil—systemic scleroderma	0.00516	0.0184	CcSEcCtD
Isoniazid—Atrophy—Prednisone—systemic scleroderma	0.0035	0.0125	CcSEcCtD
Isoniazid—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.00336	0.012	CcSEcCtD
Isoniazid—Liver injury—Captopril—systemic scleroderma	0.00322	0.0115	CcSEcCtD
Isoniazid—Neuritis—Leflunomide—systemic scleroderma	0.00299	0.0107	CcSEcCtD
Isoniazid—Diabetic—Methotrexate—systemic scleroderma	0.00285	0.0102	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Methotrexate—systemic scleroderma	0.00285	0.0102	CcSEcCtD
Isoniazid—Liver injury—Azathioprine—systemic scleroderma	0.00281	0.01	CcSEcCtD
Isoniazid—Vasculitis—Captopril—systemic scleroderma	0.00278	0.00991	CcSEcCtD
Isoniazid—Hepatocellular injury—Captopril—systemic scleroderma	0.00271	0.00967	CcSEcCtD
Isoniazid—Liver injury—Leflunomide—systemic scleroderma	0.00265	0.00948	CcSEcCtD
Isoniazid—Liver injury—Mycophenolic acid—systemic scleroderma	0.00253	0.00904	CcSEcCtD
Isoniazid—Neurotoxicity—Methotrexate—systemic scleroderma	0.00246	0.00877	CcSEcCtD
Isoniazid—Memory impairment—Lisinopril—systemic scleroderma	0.00244	0.00873	CcSEcCtD
Isoniazid—Gynaecomastia—Captopril—systemic scleroderma	0.00242	0.00866	CcSEcCtD
Isoniazid—Vasculitis—Azathioprine—systemic scleroderma	0.00242	0.00865	CcSEcCtD
Isoniazid—Hepatocellular injury—Azathioprine—systemic scleroderma	0.00236	0.00844	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Mycophenolic acid—systemic scleroderma	0.00234	0.00836	CcSEcCtD
Isoniazid—Lymphadenopathy—Captopril—systemic scleroderma	0.00231	0.00823	CcSEcCtD
Isoniazid—Vasculitis—Leflunomide—systemic scleroderma	0.00229	0.00817	CcSEcCtD
Isoniazid—Diabetes mellitus—Captopril—systemic scleroderma	0.00226	0.00807	CcSEcCtD
Isoniazid—Hepatocellular injury—Leflunomide—systemic scleroderma	0.00223	0.00797	CcSEcCtD
Isoniazid—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00222	0.00793	CcSEcCtD
Isoniazid—Hepatocellular injury—Mycophenolic acid—systemic scleroderma	0.00213	0.00761	CcSEcCtD
Isoniazid—Liver injury—Mycophenolate mofetil—systemic scleroderma	0.002	0.00713	CcSEcCtD
Isoniazid—Vasculitis—Lisinopril—systemic scleroderma	0.00197	0.00702	CcSEcCtD
Isoniazid—Hepatic function abnormal—Azathioprine—systemic scleroderma	0.00196	0.00701	CcSEcCtD
Isoniazid—Jaundice—Pentoxifylline—systemic scleroderma	0.00195	0.00696	CcSEcCtD
Isoniazid—Lymphadenopathy—Leflunomide—systemic scleroderma	0.0019	0.00678	CcSEcCtD
Isoniazid—Diabetes mellitus—Leflunomide—systemic scleroderma	0.00186	0.00665	CcSEcCtD
Isoniazid—Optic neuritis—Prednisone—systemic scleroderma	0.00185	0.00662	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Mycophenolate mofetil—systemic scleroderma	0.00185	0.0066	CcSEcCtD
Isoniazid—Lymphadenopathy—Mycophenolic acid—systemic scleroderma	0.00181	0.00647	CcSEcCtD
Isoniazid—Hepatitis—Pentoxifylline—systemic scleroderma	0.0018	0.00641	CcSEcCtD
Isoniazid—Diabetes mellitus—Mycophenolic acid—systemic scleroderma	0.00178	0.00635	CcSEcCtD
Isoniazid—Eosinophilia—Captopril—systemic scleroderma	0.00168	0.00601	CcSEcCtD
Isoniazid—Hepatocellular injury—Mycophenolate mofetil—systemic scleroderma	0.00168	0.006	CcSEcCtD
Isoniazid—Diabetes mellitus—Lisinopril—systemic scleroderma	0.0016	0.00572	CcSEcCtD
Isoniazid—Hepatic function abnormal—Lisinopril—systemic scleroderma	0.00159	0.00569	CcSEcCtD
Isoniazid—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00564	CcSEcCtD
Isoniazid—Eruption—Methotrexate—systemic scleroderma	0.00155	0.00553	CcSEcCtD
Isoniazid—Neuritis—Prednisone—systemic scleroderma	0.00153	0.00545	CcSEcCtD
Isoniazid—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.00151	0.00539	CcSEcCtD
Isoniazid—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.0015	0.00537	CcSEcCtD
Isoniazid—Jaundice—Captopril—systemic scleroderma	0.00148	0.00528	CcSEcCtD
Isoniazid—Memory impairment—Prednisone—systemic scleroderma	0.00145	0.00518	CcSEcCtD
Isoniazid—Ill-defined disorder—Pentoxifylline—systemic scleroderma	0.00145	0.00518	CcSEcCtD
Isoniazid—Lymphadenopathy—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00511	CcSEcCtD
Isoniazid—Agranulocytosis—Captopril—systemic scleroderma	0.00141	0.00505	CcSEcCtD
Isoniazid—Malaise—Pentoxifylline—systemic scleroderma	0.00141	0.00503	CcSEcCtD
Isoniazid—Diabetes mellitus—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00501	CcSEcCtD
Isoniazid—Eosinophilia—Leflunomide—systemic scleroderma	0.00139	0.00495	CcSEcCtD
Isoniazid—Hepatitis—Captopril—systemic scleroderma	0.00136	0.00486	CcSEcCtD
Isoniazid—Convulsion—Pentoxifylline—systemic scleroderma	0.00135	0.00483	CcSEcCtD
Isoniazid—Discomfort—Pentoxifylline—systemic scleroderma	0.00131	0.00469	CcSEcCtD
Isoniazid—Hyperglycaemia—Leflunomide—systemic scleroderma	0.00126	0.00451	CcSEcCtD
Isoniazid—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00125	0.00446	CcSEcCtD
Isoniazid—Agranulocytosis—Azathioprine—systemic scleroderma	0.00123	0.00441	CcSEcCtD
Isoniazid—Neuropathy peripheral—Leflunomide—systemic scleroderma	0.00122	0.00437	CcSEcCtD
Isoniazid—Jaundice—Leflunomide—systemic scleroderma	0.00122	0.00435	CcSEcCtD
Isoniazid—Anorexia—Pentoxifylline—systemic scleroderma	0.00122	0.00434	CcSEcCtD
Isoniazid—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00121	0.0043	CcSEcCtD
Isoniazid—Eosinophilia—Lisinopril—systemic scleroderma	0.00119	0.00426	CcSEcCtD
Isoniazid—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00426	CcSEcCtD
Isoniazid—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.00117	0.00417	CcSEcCtD
Isoniazid—Vasculitis—Prednisone—systemic scleroderma	0.00117	0.00417	CcSEcCtD
Isoniazid—Agranulocytosis—Leflunomide—systemic scleroderma	0.00117	0.00416	CcSEcCtD
Isoniazid—Jaundice—Mycophenolic acid—systemic scleroderma	0.00116	0.00415	CcSEcCtD
Isoniazid—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00112	0.00401	CcSEcCtD
Isoniazid—Hepatitis—Leflunomide—systemic scleroderma	0.00112	0.004	CcSEcCtD
Isoniazid—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00111	0.00397	CcSEcCtD
Isoniazid—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00111	0.00396	CcSEcCtD
Isoniazid—Ill-defined disorder—Captopril—systemic scleroderma	0.0011	0.00392	CcSEcCtD
Isoniazid—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00109	0.00388	CcSEcCtD
Isoniazid—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00107	0.00382	CcSEcCtD
Isoniazid—Malaise—Captopril—systemic scleroderma	0.00107	0.00381	CcSEcCtD
Isoniazid—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00105	0.00376	CcSEcCtD
Isoniazid—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00105	0.00375	CcSEcCtD
Isoniazid—Anorexia—Mometasone—systemic scleroderma	0.00105	0.00375	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Methotrexate—systemic scleroderma	0.00105	0.00374	CcSEcCtD
Isoniazid—Jaundice—Lisinopril—systemic scleroderma	0.00105	0.00374	CcSEcCtD
Isoniazid—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00101	0.0036	CcSEcCtD
Isoniazid—Agranulocytosis—Lisinopril—systemic scleroderma	0.001	0.00358	CcSEcCtD
Isoniazid—Discomfort—Captopril—systemic scleroderma	0.000996	0.00356	CcSEcCtD
Isoniazid—Paraesthesia—Mometasone—systemic scleroderma	0.000988	0.00353	CcSEcCtD
Isoniazid—Vasculitis—Methotrexate—systemic scleroderma	0.000976	0.00348	CcSEcCtD
Isoniazid—Dyspepsia—Mometasone—systemic scleroderma	0.000969	0.00346	CcSEcCtD
Isoniazid—Hepatitis—Lisinopril—systemic scleroderma	0.000964	0.00344	CcSEcCtD
Isoniazid—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000959	0.00342	CcSEcCtD
Isoniazid—Decreased appetite—Mometasone—systemic scleroderma	0.000957	0.00342	CcSEcCtD
Isoniazid—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000951	0.0034	CcSEcCtD
Isoniazid—Diabetes mellitus—Prednisone—systemic scleroderma	0.000951	0.0034	CcSEcCtD
Isoniazid—Fatigue—Mometasone—systemic scleroderma	0.000949	0.00339	CcSEcCtD
Isoniazid—Thrombocytopenia—Captopril—systemic scleroderma	0.000946	0.00338	CcSEcCtD
Isoniazid—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00094	0.00336	CcSEcCtD
Isoniazid—Malaise—Azathioprine—systemic scleroderma	0.000932	0.00333	CcSEcCtD
Isoniazid—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000922	0.00329	CcSEcCtD
Isoniazid—Anorexia—Captopril—systemic scleroderma	0.000921	0.00329	CcSEcCtD
Isoniazid—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000917	0.00327	CcSEcCtD
Isoniazid—Asthenia—Pentoxifylline—systemic scleroderma	0.000915	0.00327	CcSEcCtD
Isoniazid—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000906	0.00323	CcSEcCtD
Isoniazid—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000894	0.00319	CcSEcCtD
Isoniazid—Malaise—Leflunomide—systemic scleroderma	0.00088	0.00314	CcSEcCtD
Isoniazid—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000878	0.00313	CcSEcCtD
Isoniazid—Body temperature increased—Mometasone—systemic scleroderma	0.00087	0.00311	CcSEcCtD
Isoniazid—Discomfort—Azathioprine—systemic scleroderma	0.000869	0.0031	CcSEcCtD
Isoniazid—Paraesthesia—Captopril—systemic scleroderma	0.000868	0.0031	CcSEcCtD
Isoniazid—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000864	0.00309	CcSEcCtD
Isoniazid—Gynaecomastia—Methotrexate—systemic scleroderma	0.000852	0.00304	CcSEcCtD
Isoniazid—Dyspepsia—Captopril—systemic scleroderma	0.000851	0.00304	CcSEcCtD
Isoniazid—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000844	0.00301	CcSEcCtD
Isoniazid—Decreased appetite—Captopril—systemic scleroderma	0.00084	0.003	CcSEcCtD
Isoniazid—Malaise—Mycophenolic acid—systemic scleroderma	0.00084	0.003	CcSEcCtD
Isoniazid—Fatigue—Captopril—systemic scleroderma	0.000833	0.00298	CcSEcCtD
Isoniazid—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000826	0.00295	CcSEcCtD
Isoniazid—Discomfort—Leflunomide—systemic scleroderma	0.000821	0.00293	CcSEcCtD
Isoniazid—Vomiting—Pentoxifylline—systemic scleroderma	0.000811	0.0029	CcSEcCtD
Isoniazid—Lymphadenopathy—Methotrexate—systemic scleroderma	0.00081	0.00289	CcSEcCtD
Isoniazid—Psychotic disorder—Prednisone—systemic scleroderma	0.000808	0.00288	CcSEcCtD
Isoniazid—Convulsion—Mycophenolic acid—systemic scleroderma	0.000807	0.00288	CcSEcCtD
Isoniazid—Rash—Pentoxifylline—systemic scleroderma	0.000804	0.00287	CcSEcCtD
Isoniazid—Feeling abnormal—Captopril—systemic scleroderma	0.000797	0.00284	CcSEcCtD
Isoniazid—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000795	0.00284	CcSEcCtD
Isoniazid—Asthenia—Mometasone—systemic scleroderma	0.00079	0.00282	CcSEcCtD
Isoniazid—Discomfort—Mycophenolic acid—systemic scleroderma	0.000783	0.0028	CcSEcCtD
Isoniazid—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00078	0.00279	CcSEcCtD
Isoniazid—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000778	0.00278	CcSEcCtD
Isoniazid—Body temperature increased—Captopril—systemic scleroderma	0.000764	0.00273	CcSEcCtD
Isoniazid—Anorexia—Leflunomide—systemic scleroderma	0.000759	0.00271	CcSEcCtD
Isoniazid—Nausea—Pentoxifylline—systemic scleroderma	0.000758	0.00271	CcSEcCtD
Isoniazid—Malaise—Lisinopril—systemic scleroderma	0.000756	0.0027	CcSEcCtD
Isoniazid—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000744	0.00266	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000728	0.0026	CcSEcCtD
Isoniazid—Anorexia—Mycophenolic acid—systemic scleroderma	0.000724	0.00259	CcSEcCtD
Isoniazid—Paraesthesia—Leflunomide—systemic scleroderma	0.000715	0.00255	CcSEcCtD
Isoniazid—Discomfort—Lisinopril—systemic scleroderma	0.000706	0.00252	CcSEcCtD
Isoniazid—Dyspepsia—Leflunomide—systemic scleroderma	0.000701	0.0025	CcSEcCtD
Isoniazid—Vomiting—Mometasone—systemic scleroderma	0.0007	0.0025	CcSEcCtD
Isoniazid—Feeling abnormal—Azathioprine—systemic scleroderma	0.000695	0.00248	CcSEcCtD
Isoniazid—Rash—Mometasone—systemic scleroderma	0.000694	0.00248	CcSEcCtD
Isoniazid—Asthenia—Captopril—systemic scleroderma	0.000694	0.00248	CcSEcCtD
Isoniazid—Decreased appetite—Leflunomide—systemic scleroderma	0.000693	0.00247	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000688	0.00246	CcSEcCtD
Isoniazid—Fatigue—Leflunomide—systemic scleroderma	0.000687	0.00245	CcSEcCtD
Isoniazid—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000682	0.00244	CcSEcCtD
Isoniazid—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000682	0.00243	CcSEcCtD
Isoniazid—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00067	0.00239	CcSEcCtD
Isoniazid—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000669	0.00239	CcSEcCtD
Isoniazid—Body temperature increased—Azathioprine—systemic scleroderma	0.000667	0.00238	CcSEcCtD
Isoniazid—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000663	0.00237	CcSEcCtD
Isoniazid—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000661	0.00236	CcSEcCtD
Isoniazid—Feeling abnormal—Leflunomide—systemic scleroderma	0.000656	0.00234	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000656	0.00234	CcSEcCtD
Isoniazid—Fatigue—Mycophenolic acid—systemic scleroderma	0.000655	0.00234	CcSEcCtD
Isoniazid—Nausea—Mometasone—systemic scleroderma	0.000654	0.00233	CcSEcCtD
Isoniazid—Anorexia—Lisinopril—systemic scleroderma	0.000653	0.00233	CcSEcCtD
Isoniazid—Hyperglycaemia—Prednisone—systemic scleroderma	0.000645	0.0023	CcSEcCtD
Isoniazid—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000637	0.00227	CcSEcCtD
Isoniazid—Body temperature increased—Leflunomide—systemic scleroderma	0.00063	0.00225	CcSEcCtD
Isoniazid—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000626	0.00224	CcSEcCtD
Isoniazid—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000625	0.00223	CcSEcCtD
Isoniazid—Hypersensitivity—Azathioprine—systemic scleroderma	0.000622	0.00222	CcSEcCtD
Isoniazid—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000618	0.00221	CcSEcCtD
Isoniazid—Paraesthesia—Lisinopril—systemic scleroderma	0.000615	0.00219	CcSEcCtD
Isoniazid—Vomiting—Captopril—systemic scleroderma	0.000615	0.00219	CcSEcCtD
Isoniazid—Rash—Captopril—systemic scleroderma	0.000609	0.00218	CcSEcCtD
Isoniazid—Dyspepsia—Lisinopril—systemic scleroderma	0.000603	0.00215	CcSEcCtD
Isoniazid—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000601	0.00215	CcSEcCtD
Isoniazid—Decreased appetite—Lisinopril—systemic scleroderma	0.000595	0.00212	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—systemic scleroderma	0.000592	0.00211	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000591	0.00211	CcSEcCtD
Isoniazid—Fatigue—Lisinopril—systemic scleroderma	0.00059	0.00211	CcSEcCtD
Isoniazid—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000587	0.0021	CcSEcCtD
Isoniazid—Hypersensitivity—Leflunomide—systemic scleroderma	0.000587	0.0021	CcSEcCtD
Isoniazid—Nausea—Captopril—systemic scleroderma	0.000574	0.00205	CcSEcCtD
Isoniazid—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000572	0.00204	CcSEcCtD
Isoniazid—Asthenia—Leflunomide—systemic scleroderma	0.000572	0.00204	CcSEcCtD
Isoniazid—Feeling abnormal—Lisinopril—systemic scleroderma	0.000564	0.00201	CcSEcCtD
Isoniazid—Asthenia—Mycophenolic acid—systemic scleroderma	0.000545	0.00195	CcSEcCtD
Isoniazid—Body temperature increased—Lisinopril—systemic scleroderma	0.000541	0.00193	CcSEcCtD
Isoniazid—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000539	0.00192	CcSEcCtD
Isoniazid—Vomiting—Azathioprine—systemic scleroderma	0.000536	0.00192	CcSEcCtD
Isoniazid—Rash—Azathioprine—systemic scleroderma	0.000532	0.0019	CcSEcCtD
Isoniazid—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000528	0.00189	CcSEcCtD
Isoniazid—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000521	0.00186	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000518	0.00185	CcSEcCtD
Isoniazid—Vomiting—Leflunomide—systemic scleroderma	0.000507	0.00181	CcSEcCtD
Isoniazid—Hypersensitivity—Lisinopril—systemic scleroderma	0.000504	0.0018	CcSEcCtD
Isoniazid—Rash—Leflunomide—systemic scleroderma	0.000502	0.00179	CcSEcCtD
Isoniazid—Nausea—Azathioprine—systemic scleroderma	0.000501	0.00179	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—systemic scleroderma	0.000497	0.00178	CcSEcCtD
Isoniazid—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000494	0.00176	CcSEcCtD
Isoniazid—Asthenia—Lisinopril—systemic scleroderma	0.000491	0.00175	CcSEcCtD
Isoniazid—Vomiting—Mycophenolic acid—systemic scleroderma	0.000483	0.00173	CcSEcCtD
Isoniazid—Rash—Mycophenolic acid—systemic scleroderma	0.000479	0.00171	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—systemic scleroderma	0.000478	0.00171	CcSEcCtD
Isoniazid—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000474	0.00169	CcSEcCtD
Isoniazid—Nausea—Leflunomide—systemic scleroderma	0.000473	0.00169	CcSEcCtD
Isoniazid—Ill-defined disorder—Prednisone—systemic scleroderma	0.000462	0.00165	CcSEcCtD
Isoniazid—Nausea—Mycophenolic acid—systemic scleroderma	0.000451	0.00161	CcSEcCtD
Isoniazid—Malaise—Prednisone—systemic scleroderma	0.000449	0.0016	CcSEcCtD
Isoniazid—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000442	0.00158	CcSEcCtD
Isoniazid—Vomiting—Lisinopril—systemic scleroderma	0.000435	0.00155	CcSEcCtD
Isoniazid—Rash—Lisinopril—systemic scleroderma	0.000432	0.00154	CcSEcCtD
Isoniazid—Convulsion—Prednisone—systemic scleroderma	0.000432	0.00154	CcSEcCtD
Isoniazid—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00043	0.00154	CcSEcCtD
Isoniazid—Discomfort—Prednisone—systemic scleroderma	0.000419	0.0015	CcSEcCtD
Isoniazid—Nausea—Lisinopril—systemic scleroderma	0.000407	0.00145	CcSEcCtD
Isoniazid—Anorexia—Prednisone—systemic scleroderma	0.000388	0.00138	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000386	0.00138	CcSEcCtD
Isoniazid—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000381	0.00136	CcSEcCtD
Isoniazid—Rash—Mycophenolate mofetil—systemic scleroderma	0.000378	0.00135	CcSEcCtD
Isoniazid—Malaise—Methotrexate—systemic scleroderma	0.000375	0.00134	CcSEcCtD
Isoniazid—Paraesthesia—Prednisone—systemic scleroderma	0.000365	0.0013	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—systemic scleroderma	0.000361	0.00129	CcSEcCtD
Isoniazid—Dyspepsia—Prednisone—systemic scleroderma	0.000358	0.00128	CcSEcCtD
Isoniazid—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000356	0.00127	CcSEcCtD
Isoniazid—Decreased appetite—Prednisone—systemic scleroderma	0.000353	0.00126	CcSEcCtD
Isoniazid—Fatigue—Prednisone—systemic scleroderma	0.000351	0.00125	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—systemic scleroderma	0.00035	0.00125	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisone—systemic scleroderma	0.000335	0.0012	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000333	0.00119	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—systemic scleroderma	0.000324	0.00116	CcSEcCtD
Isoniazid—Body temperature increased—Prednisone—systemic scleroderma	0.000321	0.00115	CcSEcCtD
Isoniazid—Paraesthesia—Methotrexate—systemic scleroderma	0.000305	0.00109	CcSEcCtD
Isoniazid—Hypersensitivity—Prednisone—systemic scleroderma	0.0003	0.00107	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—systemic scleroderma	0.000299	0.00107	CcSEcCtD
Isoniazid—Decreased appetite—Methotrexate—systemic scleroderma	0.000295	0.00105	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000293	0.00105	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—systemic scleroderma	0.000293	0.00105	CcSEcCtD
Isoniazid—Asthenia—Prednisone—systemic scleroderma	0.000292	0.00104	CcSEcCtD
Isoniazid—Feeling abnormal—Methotrexate—systemic scleroderma	0.00028	0.001	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—systemic scleroderma	0.000269	0.000959	CcSEcCtD
Isoniazid—Vomiting—Prednisone—systemic scleroderma	0.000258	0.000923	CcSEcCtD
Isoniazid—Rash—Prednisone—systemic scleroderma	0.000256	0.000915	CcSEcCtD
Isoniazid—Hypersensitivity—Methotrexate—systemic scleroderma	0.00025	0.000894	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—systemic scleroderma	0.000244	0.00087	CcSEcCtD
Isoniazid—Nausea—Prednisone—systemic scleroderma	0.000241	0.000862	CcSEcCtD
Isoniazid—Vomiting—Methotrexate—systemic scleroderma	0.000216	0.000771	CcSEcCtD
Isoniazid—Rash—Methotrexate—systemic scleroderma	0.000214	0.000765	CcSEcCtD
Isoniazid—Nausea—Methotrexate—systemic scleroderma	0.000202	0.000721	CcSEcCtD
